Search research articles
Contact Us
Filters
Showing results (111-120 of 113) with videos related to
Page
of 12
Sort By:
You have reached the last page of results.
This site can display upto 113 results.
Leukemia & Lymphoma
|
January 8, 2015
Phase I dose escalation study of lestaurtinib in patients with myelofibrosis
Elizabeth O Hexner, John Mascarenhas, Josef Prchal, et al.
Journal of the American College of Cardiology
|
November 12, 2013
Vorapaxar in acute coronary syndrome patients undergoing coronary artery bypass graft surgery: subgroup analysis from the TRACER trial (Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome)
David J Whellan, Pierluigi Tricoci, Edmond Chen, et al.
Blood
|
September 14, 2019
Pegylated interferon alfa-2a for polycythemia vera or essential thrombocythemia resistant or intolerant to hydroxyurea
Abdulraheem Yacoub, John Mascarenhas, Heidi Kosiorek, et al.
Page
of 12
Search research articles
Search
Showing results (111-120 of 113) with videos related to
Sort By:
Page
of 12
You have reached the last page of results.
This site can display upto 113 results.
Leukemia & Lymphoma
|
January 8, 2015
Phase I dose escalation study of lestaurtinib in patients with myelofibrosis
Elizabeth O Hexner, John Mascarenhas, Josef Prchal, et al.
Journal of the American College of Cardiology
|
November 12, 2013
Vorapaxar in acute coronary syndrome patients undergoing coronary artery bypass graft surgery: subgroup analysis from the TRACER trial (Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome)
David J Whellan, Pierluigi Tricoci, Edmond Chen, et al.
Blood
|
September 14, 2019
Pegylated interferon alfa-2a for polycythemia vera or essential thrombocythemia resistant or intolerant to hydroxyurea
Abdulraheem Yacoub, John Mascarenhas, Heidi Kosiorek, et al.
Page
of 12